Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 4/20 | 0.60 |
| ▸ | DRD4 | P21917 | 5/20 | 0.50 |
| ▸ | DRD2 | P14416 | 7/20 | 0.49 |
| ▸ | DRD3 | P35462 | 2/20 | 0.49 |
| ▸ | HTR1A | P08908 | 6/20 | 0.48 |
| ▸ | HTR2A | P28223 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HTR6 | P50406 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7610245 | 0.99 | HTR7 (0.59) | HTR7DRD4DRD2DRD3HTR1A | |
| SCHEMBL6475262 | 0.91 | HTR7 (0.58) | HTR7DRD4DRD2DRD3HTR1A | |
| Hydrochloric Acid SCHEMBL7100442 | 0.90 | HTR7 (0.57) | HTR7DRD4DRD2DRD3HTR1A | |
| SCHEMBL6474401 | 0.81 | HTR7 (0.60) | HTR7DRD2HTR1AHTR2AKDM4E | |
| SCHEMBL6475395 | 0.81 | HTR1A (0.67) | HTR7DRD4DRD2DRD3HTR1A | |
| SCHEMBL6860233 | 0.81 | DRD4 (0.52) | HTR7DRD4DRD2DRD3HTR1A | |
| SCHEMBL6474190 | 0.81 | HTR7 (0.69) | HTR7DRD4DRD2DRD3HTR1A | |
| SCHEMBL6474706 | 0.81 | HTR7 (0.60) | HTR7DRD4DRD2DRD3HTR1A | |
| Hydrochloric Acid SCHEMBL7613022 | 0.81 | HTR7 (0.59) | HTR7DRD4DRD2HTR1AHTR2A | |
| SCHEMBL6483189 | 0.81 | HTR7 (0.56) | HTR7DRD2HTR1AHTR2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6914064-B2 | 1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers | RANBAXY LABORATORIES LIMITED (IN) | 2005-07-05 | — | — | US | claimed |
| US-20020156085-A1 | 1,4-Disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers | RANBAXY LABORATORIES LIMITED (IN) | 2002-10-24 | — | — | US | claimed |
| US-6914064-B2 | 1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers | RANBAXY LABORATORIES LIMITED (IN) | 2005-07-05 | — | — | US | disclosed |
| US-20020156085-A1 | 1,4-Disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers | RANBAXY LABORATORIES LIMITED (IN) | 2002-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156085-A1 | 1,4-Disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers | ADRB1, ADRB2, ADRA1B | HTR7 426/4885DRD4 1105/4885DRD2 491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.